SPRUCE BIOSCIENCES, INC. Debt-to-equity in % from Q2 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Spruce Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2025.
  • Spruce Biosciences, Inc. Debt-to-equity for the quarter ending September 30, 2025 was 81.8 %, a 166% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

SPRUCE BIOSCIENCES, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 81.8 +51 +166% Sep 30, 2025
Q2 2025 50.3 +18.2 +56.8% Jun 30, 2025
Q1 2025 40.4 +7.94 +24.5% Mar 31, 2025
Q4 2024 32.5 +1.01 +3.2% Dec 31, 2024
Q3 2024 30.8 +1.41 +4.8% Sep 30, 2024
Q2 2024 32.1 +5.2 +19.3% Jun 30, 2024
Q1 2024 32.4 +9.02 +38.6% Mar 31, 2024
Q4 2023 31.5 +12.5 +65.4% Dec 31, 2023
Q3 2023 29.4 +13 +79.4% Sep 30, 2023
Q2 2023 26.9 +12.5 +86.5% Jun 30, 2023
Q1 2023 23.4 +10.7 +84.3% Mar 31, 2023
Q4 2022 19.1 +7.69 +67.6% Dec 31, 2022
Q3 2022 16.4 +6.1 +59.4% Sep 30, 2022
Q2 2022 14.4 -0.37 -2.5% Jun 30, 2022
Q1 2022 12.7 Mar 31, 2022
Q4 2021 11.4 Dec 31, 2021
Q3 2021 10.3 Sep 30, 2021
Q2 2021 14.8 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.